Review | Role of GLP1 receptor agonists in achieving weight loss and improving CV outcomes in people with overweight and obesity 19 Jun, 2023 | 13:40h | UTC Role of Glucagon‐Like Peptide‐1 Receptor Agonists in Achieving Weight Loss and Improving Cardiovascular Outcomes in People With Overweight and Obesity – Journal of the American Heart Association